Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.
about
Mass Spectrometry-Based Proteomics for Investigating DNA Damage-Associated Protein UbiquitylationCullin 3 Ubiquitin Ligases in Cancer Biology: Functions and Therapeutic ImplicationsDissecting the Potential Interplay of DEK Functions in Inflammation and CancerQuantifying ubiquitin signalingSystematic approaches to identify E3 ligase substratesThe importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistanceDysregulation of ubiquitin ligases in cancerComprehensive assessment of cancer missense mutation clustering in protein structuresThe polar warhead of a TRIM24 bromodomain inhibitor rearranges a water-mediated interaction network.Exploiting Epigenetic Alterations in Prostate Cancer.Roles of ubiquitination and SUMOylation on prostate cancer: mechanisms and clinical implications.Application of quantitative proteomics to the integrated analysis of the ubiquitylated and global proteomes of xenograft tumor tissuesSPOP mutation leads to genomic instability in prostate cancer.SPOP E3 Ubiquitin Ligase Adaptor Promotes Cellular Senescence by Degrading the SENP7 deSUMOylasePrecision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials.Systematic Prioritization of Druggable Mutations in ∼5000 Genomes Across 16 Cancer Types Using a Structural Genomics-based ApproachMultiple Weak Linear Motifs Enhance Recruitment and Processivity in SPOP-Mediated Substrate Ubiquitination.Speckle-type POZ (pox virus and zinc finger protein) protein gene deletion in ovarian cancer: Fluorescence in situ hybridization analysis of a tissue microarrayHigher-order oligomerization promotes localization of SPOP to liquid nuclear speckles.TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.SPOP-containing complex regulates SETD2 stability and H3K36me3-coupled alternative splicing.Silencing speckle-type POZ protein by promoter hypermethylation decreases cell apoptosis through upregulating Hedgehog signaling pathway in colorectal cancerMoving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer.Implications of ubiquitin ligases in castration-resistant prostate cancer.RNF167 targets Arl8B for degradation to regulate lysosome positioning and endocytic trafficking.The genomic evolution of human prostate cancer.New advances in genitourinary cancer: evidence gathered in 2014.Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.Discovery of a Chemical Tool Inhibitor Targeting the Bromodomains of TRIM24 and BRPF.Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.Cullin 3SPOP ubiquitin E3 ligase promotes the poly-ubiquitination and degradation of HDAC6.Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.Molecular subtyping of prostate cancer.Clinical variability and molecular heterogeneity in prostate cancer.SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.SPOP Promotes Ubiquitination and Degradation of the ERG Oncoprotein to Suppress Prostate Cancer Progression.Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine.Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsIdentification of DEK as a potential therapeutic target for neuroendocrine prostate cancer.
P2860
Q26744515-86DDEABE-066B-42F6-AC94-F76C2800B8E4Q26747274-1B453AD9-2775-41B6-B9D6-A691D715A592Q26783559-B7F99261-7FEC-4748-8D8C-4B00BC7EBB7BQ26823466-8FEB5247-0EFA-4065-B739-B8F0AC8E9777Q28068398-418A097E-C4CC-424F-A1D9-9F89F7946A00Q28076745-93D4C69C-A77A-4739-9CB2-83AFBE3D960EQ28086796-257758B6-F09D-4BB0-8038-E617A702EDF5Q28606437-5E8772C6-3125-46ED-9CF6-106530539B5DQ31162467-8282E4BB-50AD-4EF6-98C3-D745E647807AQ33755160-0DF76801-A3D9-4CDF-BC2C-22EE2761E334Q35380380-8B50A102-D587-44F0-BE06-A24E4A4E967BQ35652100-3F1F7FFA-7F15-4608-973C-3774D7588BA9Q36210354-AF568B64-6174-443E-804D-3F834E77ADA9Q36278928-7C7DE7C4-656E-46D6-9C2F-9DA985A3E1AAQ36288987-6F557AC1-2CD7-409A-9B1C-A41BEF564831Q36539506-31514126-4199-4096-AAE7-DDCC851990B6Q36782739-F097851F-F274-42A9-810D-20583A407DD6Q37002758-37E8DBC5-D187-46F8-A59C-B00C0311116BQ37011857-B3914F9A-F964-4B08-AD57-BBB219F9B42CQ37443033-59F0532E-CD81-45E9-AFA5-A95D1C561318Q37452209-5F015187-C4AB-46D7-8874-DF254DA8ED03Q37577424-CD434AA0-140D-4BE9-A119-8402FF4082C0Q37603495-D0ACCE16-89B1-48A2-9C9B-5070CD44F863Q37737611-842D7CA7-ECC7-40A8-A747-D37D2B9AD5C1Q38391804-78ECFB50-0A6F-483E-B48E-562B29214AACQ38409024-D8138732-2787-4E8A-B04B-DC983A7FDE5EQ38540636-FCE27F0C-0FE6-45F9-BC35-FE7AA118C494Q38557894-C1FCEC7E-7CDA-41F3-8FCA-40F7FE9F1888Q38626078-2DDCFBA8-3F61-40C4-AC3F-37A660BC173EQ38668625-DD612729-9678-4D8F-9500-E37E48835BFAQ38705858-55231276-64B4-445E-AF8E-5A7E4E60752CQ38733838-B8511400-39C0-4A77-80FA-4BEC549966B0Q38768101-36772D04-9A13-4D28-9370-931A4F841F6AQ38778266-BCDCBC56-FC3F-4153-A7A7-E339A15396FFQ38808811-B5AF60FE-097A-42E2-8057-E988BC7CBCD0Q38834625-F8B106E9-3E9B-44D4-BF5D-674AE7D258C2Q38837458-0C96EAAE-E841-4DE0-9954-7364B1EA8EECQ39044222-58D58DAD-55BC-47BC-8C3A-BA7187A09FE6Q41414462-D722D2C7-9F5E-4C50-AE19-A5922BFE759CQ41830742-0826278B-A22B-4AE9-B7C3-B73C032FF2AC
P2860
Prostate cancer. Ubiquitylome analysis identifies dysregulation of effector substrates in SPOP-mutant prostate cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@ast
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@en
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@nl
type
label
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@ast
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@en
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@nl
prefLabel
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@ast
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@en
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@nl
P2093
P2860
P50
P356
P1433
P1476
Prostate cancer. Ubiquitylome ...... n SPOP-mutant prostate cancer.
@en
P2093
Anna C Groner
Holger Moch
Jean-Philippe P Theurillat
Marius Pop
Mirjam Blattner
Namrata D Udeshi
Peter J Wild
Steven A Carr
Sylvan C Baca
Tanya Svinkina
P2860
P356
10.1126/SCIENCE.1250255
P407
P577
2014-10-02T00:00:00Z